Balding Hair Follicle Dermal Papilla Cells Contain Higher Levels of Androgen Receptors Than Those From Non-Balding Scalp

    January 1998 in “ Journal of Endocrinology
    Nigel A. Hibberts, Anthea Howell, Valerie A. Randall
    Image of study
    TLDR Cells from balding scalps have more androgen receptors than cells from non-balding scalps.
    In the 1998 study by Hibberts, Howell, and Randall, it was discovered that dermal papilla cells from the scalp hair follicles of balding individuals had significantly higher levels of androgen receptors than those from non-balding individuals. The study included 11 participants (10 men and 1 woman) with an average age of 34 years. The androgen receptor content was measured using [³H]mibolerone, and the results indicated that balding cells had 0.06 ± 0.01 fmol/10⁴ cells, which was significantly higher than the 0.04 ± 0.001 fmol/10⁴ cells found in non-balding cells, with a significance of P<0.01. The binding affinity for androgen receptors was similar between balding and non-balding samples, but the maximum binding capacity was significantly higher in balding samples. This supports the idea that androgens may contribute to androgenetic alopecia through their action on the dermal papilla and that cultured dermal papilla cells could be a useful model for studying this condition.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 1000+ results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Related Research

    7 / 7 results